{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T18:15:24Z","timestamp":1785867324392,"version":"3.56.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":844,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","seizure-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seizure"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.seizure.2010.12.011","type":"journal-article","created":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T07:09:07Z","timestamp":1294988947000},"page":"343-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients"],"prefix":"10.1016","volume":"20","author":[{"given":"Soodeh Razeghi","family":"Jahromi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansoureh","family":"Togha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohrab Hashemi","family":"Fesharaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoumeh","family":"Najafi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nahid Beladi","family":"Moghadam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jalil Arab","family":"Kheradmand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadi","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Gorji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"Suppl. 4","key":"10.1016\/j.seizure.2010.12.011_bib0005","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1528-1167.2005.463007.x","article-title":"An introduction to antiepileptic drugs","volume":"46","author":"Perucca","year":"2005","journal-title":"Epilepsia"},{"issue":"4","key":"10.1016\/j.seizure.2010.12.011_bib0010","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.clineuro.2009.12.014","article-title":"Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients","volume":"112","author":"Zeng","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/j.seizure.2010.12.011_bib0015","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.seizure.2005.01.008","article-title":"Complaints associated with the use of antiepileptic drugs: results from a community-based study","volume":"14","author":"Carpay","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.seizure.2010.12.011_bib0020","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.yebeh.2008.02.001","article-title":"Efficacy, tolerability, and side effects of oxcarbazepine monotherapy: a prospective study in adult and elderly patients with newly diagnosed partial epilepsy","volume":"13","author":"Dogan","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2010.12.011_bib0025","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11060-007-9373-8","article-title":"Retrospective analysis of the efficacy and tolerability of levetiracetam in patients with metastatic brain tumors","volume":"84","author":"Newton","year":"2007","journal-title":"J Neurooncol"},{"key":"10.1016\/j.seizure.2010.12.011_bib0030","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1600-0404.2005.00506.x","article-title":"Adverse effects of antiepileptic drugs","volume":"181","author":"Perucca","year":"2005","journal-title":"Acta Neurol Scand Suppl"},{"key":"10.1016\/j.seizure.2010.12.011_bib0035","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00228-006-0236-6","article-title":"Use and safety profile of antiepileptic drugs in Italy","volume":"63","author":"Iorio","year":"2007","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.seizure.2010.12.011_bib0040","series-title":"Valprote. Bruinvels J. Valproate","first-page":"224","article-title":"Adverse effects and interactions with other drugs","author":"Schmidt","year":"1999"},{"key":"10.1016\/j.seizure.2010.12.011_bib0045","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0920-1211(97)00024-7","article-title":"A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy","volume":"27","author":"Bill","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.12.011_bib0050","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s002130000380","article-title":"Carbamazepine and valproate monotherapy: feasibility, relative safety and efficacy, and therapeutic drug monitoring in manic disorder","volume":"150","author":"Vasudev","year":"2000","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.seizure.2010.12.011_bib0055","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.yebeh.2004.03.002","article-title":"Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center","volume":"5","author":"Bootsma","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.seizure.2010.12.011_bib0060","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0920-1211(96)01013-3","article-title":"A double-blind controlled clinical trial: oxcarbazepine versus sodium valproate in adults with newly diagnosed epilepsy","volume":"26","author":"Christe","year":"1997","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.seizure.2010.12.011_bib0065","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1528-1157.1988.tb04237.x","article-title":"Clinical side effects of phenobarbital, primidone, phenytoin, carbamazepine, and valproate during monotherapy in children","volume":"29","author":"Herranz","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.12.011_bib0070","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1517\/14740338.2.4.421","article-title":"Gastrointestinal side effects of drugs","volume":"2","author":"Makins","year":"2003","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.seizure.2010.12.011_bib0075","series-title":"Antiepileptic drugs","first-page":"837","article-title":"Valproic acid adverse effects","author":"Genton","year":"2002"},{"key":"10.1016\/j.seizure.2010.12.011_bib0080","doi-asserted-by":"crossref","DOI":"10.1007\/BF00431417","article-title":"Oropharyngeal dysphagia due to iatrogenic neurological dysfunction","volume":"10","author":"Buchholz","year":"1995","journal-title":"Dysphagia"},{"key":"10.1016\/j.seizure.2010.12.011_bib0085","doi-asserted-by":"crossref","DOI":"10.1046\/j.1528-1157.2002.13001.x","article-title":"The importance of drug interactions in epilepsy therapy","volume":"43","author":"Patsalos","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.seizure.2010.12.011_bib0090","series-title":"Harrison's principles of internal medicine","author":"Fauci","year":"2008"}],"container-title":["Seizure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110003328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1059131110003328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T01:39:57Z","timestamp":1761010797000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1059131110003328"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1059131110003328"],"URL":"https:\/\/doi.org\/10.1016\/j.seizure.2010.12.011","relation":{},"ISSN":["1059-1311"],"issn-type":[{"value":"1059-1311","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gastrointestinal adverse effects of antiepileptic drugs in intractable epileptic patients","name":"articletitle","label":"Article Title"},{"value":"Seizure","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seizure.2010.12.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}